Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
11732
Beskrivning
The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI).
Nyckelord
Versioner (2)
- 2015-07-28 2015-07-28 -
- 2015-11-21 2015-11-21 -
Uppladdad den
28 juli 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Criteria: Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
Similar models
Eligibility criteria
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Informed consent
Item
Provision of signed informed consent
boolean
C0021430 (UMLS CUI-1)
STEMI
Item
Index event of ST segment elevation ACS
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
Index event of non-ST segment elevation ACS
boolean
C3537184 (UMLS CUI-1)
PCI complication
Item
Index event is an acute complication of percutaneous coronary intervention
boolean
PCI
Item
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
boolean
C1532338 (UMLS CUI-1)
anticoagulation therapy
Item
Oral anticoagulation therapy that cannot be stopped
boolean
C0003281 (UMLS CUI-1)
Bradycardia
Item
The conditions associated with increased risk of bradycardiac events
boolean
C0428977 (UMLS CUI-1)